5-(Hydroxymethyl)pyrimidine-2,4(1H,3H)-dione, 98.0%, 10g

6-Chlorobenzo[d]thiazole, 95.0%, 250mg

Ethyl 4-benzyloxycarbonylamino-3-hydroxy-1-methyl-1H-pyrrole-2-carboxylate, 1g

D-(-)-Leucinol>97.0%(GC)(T)5g

4,4'-Bipyridine -1,1'-dioxide, 97.0%, 10g

Ethyl 1-(2-Fluoro-phenyl)-5-trifluoromethyl-1H-pyrazole-4-carboxylate, 97.0%, 1g

4-Cyano-2-(trifluoromethyl)benzoic acid, 95.0%, 250mg

Columna HPLC NUCLEODUR® 100-3 C18 ec 3 µm, 100 mm, 4 mm, 1 Pieza(s)

2-Propenamide, 3-(3-chlorophenyl)-N-[2-[methyl(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)amino]-2-oxoethyl]-, (2E)-, 100mg

Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate, 95.0%, 1g

Lithium Formate Monohydrate>98.0%(T)500g

6-Chloroimidazo[1,2-a]pyridine-8-carboxylic acid, 95.0%, 1g

1-Difluoromethanesulfonyl-4-fluorobenzene, 95%, 10g